Motilal Oswal initiated coverage on Canara HSBC Life Insurance with a ‘Buy’ rating. The brokerage has set the target price on the stock at Rs 180, which is an upside of 23% from the current market price.
Motilal Oswal believes that the life insurer “offers a rare multi-year compounding opportunity anchored in a structurally improving banca engine, rising contribution from premiumised HSBC flows, and disciplined agency expansion.”
Here are the key reasons why the brokerage firm is bullish –
Strategic distribution backbone and massive customer funnel
Canara HSBC Life is a bank-led insurance firm that leverages the extensive distribution networks of its parent banks, with Canara Bank contributing 70% and HSBC contributing 15% of the business as of H1 FY26. Canara Bank provides an embedded base of 120 million customers, offering long-duration, low-cost growth visibility.
Significant headroom for productivity improvement
Motilal Oswal said that there is a massive growth runway due to the current low productivity. Canara Bank’s branch productivity is just Rs 0.16 crore compared to Rs 0.5 crore for other private banks. The brokerage expects that even a partial convergence to higher productivity levels will drive a 21% APE CAGR from this channel through FY28.
Unlocking premium clientele via HSBC
Motilal Oswal pointed out that after Canara Bank, HSBC serves as a second pillar in the distribution architecture, providing access to high-quality affluent segments, including NRIs and high-net-worth individuals. With approval to add 20 new branches in India, HSBC is expected further to augment the premier and profitable clientele for the insurer.
VNB margin expansion through product mix and efficiency
Canara HSBC Life Insurance is executing a strategy to shift its product mix toward higher-margin protection and non-par savings products. According to Motilal Oswal, this, combined with technology-driven cost efficiencies, VNB margins are estimated to expand by 50 basis points annually over the next few years, aiming to improve the opex ratio to 10% by FY28.
Market-outperforming growth and favourable valuation
Over the past decade, Canara HSBC Life Insurance has outperformed the industry and the private segment with a 22% CAGR in APE, which resulted in consistent market share gains. Despite this performance, Motilal Oswal said that the company is trading at a favourable valuation compared to its listed peers, valuing it at 1.7x for FY28 to its enterprise value.
Industry tailwinds
Motilal Oswal believes that the industry is well-positioned to deliver strong growth traction, helped by increasing penetration (India’s penetration at 2.8% vs. global 2.9%), GST exemption tailwind, narrowing protection gap in the country (83% in India, highest among peers), and expected favourable regulations such as risk-based solvency, composite license, etc.
As the bank has a high dependence on its parents. This brings some risks as well. Here are the key risks that can affect the business of Canara HSBC Life-
Dependency on Canara Bank’s operational execution
The life insurer’s major portion of the growth relies on improving productivity within the Canara Bank network. Slower-than-expected branch activation (as roughly 3,500 of 9,800 branches are currently inactive) or failure to improve branch productivity toward higher industry levels could delay the projected APE compounding and margin expansion.
Regulatory and operational pressures
The Canara HSBC Life Insurance faces risks from adverse regulatory changes, such as potential caps on bancassurance commissions or shifting surrender value regulations that could contract margins. Furthermore, persistent underperformance could negatively affect long-term profitability and the compounding path. The reason for that could be driven by either customer behaviour or operational lapses in renewal management.
All in all, with one of the most underpenetrated PSU-bank funnels and clear visibility on branch activation, product mix upgrades and operating leverage, Motilal Oswal expects the company to deliver over 17% operating return on enterprise value going ahead, despite near-term ITC and agency drag.
Disclaimer: This article provides factual analysis only and is not, and should not be construed as, an offer, solicitation, or recommendation to buy or sell securities. Investors must conduct their own independent due diligence and seek advice from a SEBI-registered financial advisor.